Financhill
Back

Enliven Therapeutics Quote, Financials, Valuation and Earnings

Buy
61

ELVN
Enliven Therapeutics

Last Price:
23.05
Seasonality Move:
-14.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Enliven Therapeutics Price Quote

$23.05
+0.01 (+-3.19%)
(Updated: May 18, 2024 at 5:41 AM ET)

Enliven Therapeutics Key Stats

Buy
61
Enliven Therapeutics (ELVN) is a Buy

Day range:
$22.92 - $24.00
52-week range:
$9.80 - $26.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.41%

Volume:
216.7K
Avg. volume:
470.8K
1-year change:
15.2%
Market cap:
$1.1B
Revenue:
$0
EPS:
$-1.92

How Much Does Enliven Therapeutics Make?

Data Unavailable

Is Enliven Therapeutics Growing As A Company?

Data Unavailable

Enliven Therapeutics Stock Price Performance

What Is Enliven Therapeutics 52-Week High & Low?

Enliven Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Enliven Therapeutics?

Is Enliven Therapeutics Cash Flow Positive?

  • What Is ELVN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$63.8M
  • What Is Enliven Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $87.1M
  • What Is Enliven Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$166.3M

Enliven Therapeutics Return On Invested Capital

Data Unavailable

Enliven Therapeutics Earnings Date & Stock Price

Enliven Therapeutics Competitors

Enliven Therapeutics Dividend Yield

Data Unavailable

Enliven Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.33
Upside from Last Price: 49.02%

Major Shareholders

  • How many ELVN shares are owned by institutional investors?
    54.2M ELVN shares are owned by institutional investors
  • How many ELVN shares are owned by insiders?
    261.6K ELVN shares are owned by insiders